Figure 2.

Kaplan-Meier curves for (A) overall survival (OS) and (B) progression free survival (PFS) for patients with EGFR-mRNA > median expression (n = 65) and EGFR-mRNA < median expression (n = 65). Median OS: 6.8 vs 10.7 months, p = 0.173; median PFS: 2.9 vs 5.9 months, p = 0.116.

Atmaca et al. BMC Cancer 2012 12:524   doi:10.1186/1471-2407-12-524
Download authors' original image